CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-12 | Atkins Susan E. Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-06-15 | Rodriguez Javier See Remarks | Option exercise | +35 | 26,838 | ||
| 2026-06-15 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −35 | 212 | ||
| 2026-06-15 | Steinhart Richard I Chief Financial Officer | Option exercise | +35 | 26,335 | ||
| 2026-06-15 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −35 | 212 | ||
| 2026-06-15 | Yocca Frank Chief Scientific Officer | Option exercise | +35 | 26,210 | ||
| 2026-06-15 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −35 | 212 | ||
| 2026-06-15 | Mehta Vimal CEO and President | Option exercise | +219 | 69,817 | ||
| 2026-06-15 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units | −219 | 1,313 | ||
| 2026-05-20 | Yocca Frank Chief Scientific Officer | Sale 10b5-1 | −6,845 | $1.09 | $7K | 26,175 |
| 2026-05-20 | Rodriguez Javier See Remarks | Sale 10b5-1 | −6,560 | $1.08 | $7K | 26,803 |
| 2026-05-20 | Steinhart Richard I Chief Financial Officer | Sale 10b5-1 | −6,845 | $1.09 | $7K | 26,300 |
| 2026-05-20 | Mehta Vimal CEO and President | Sale 10b5-1 | −19,419 | $1.09 | $21K | 69,598 |
| 2026-05-04 | Yocca Frank Chief Scientific Officer | Option exercise 10b5-1 | +17,500 | 33,020 | ||
| 2026-05-04 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units 10b5-1 | −17,500 | 52,500 | ||
| 2026-05-04 | Rodriguez Javier See Remarks | Option exercise 10b5-1 | +17,500 | 33,363 | ||
| 2026-05-04 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −17,500 | 52,500 | ||
| 2026-05-04 | Steinhart Richard I Chief Financial Officer | Option exercise 10b5-1 | +17,500 | 33,145 | ||
| 2026-05-04 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −17,500 | 52,500 | ||
| 2026-05-04 | Mehta Vimal CEO and President | Option exercise 10b5-1 | +49,758 | 89,017 |
Page 1 of 27 · 521 trades